Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

MOLECULAR MARKETS NON-INVASIVE DETECTOR

Nov. 12, 1991

IMMUNOMEDICS SEEKS EUROPEAN APPROVAL

Nov. 12, 1991

PHARMATEC CLOSES ON FINANCING

Nov. 12, 1991

IDEXX ACQUIRES TEST MANUFACTURER

Nov. 12, 1991

RATIONAL DESIGN FOR HYPERTENSION DRUG

Nov. 11, 1991

CAMBRIDGE NEURO RAISES $18.4 MILLION

Nov. 11, 1991

FDA APPROVES NICODERM PATCH

Nov. 11, 1991

DRUG APPROVAL OVERHAUL PLANS

Nov. 11, 1991

APPOINTMENTS AND ADVANCEMENTS

Nov. 11, 1991

CENTOCOR LOSES $34.9 MILLION IN QUARTER

Nov. 11, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...